46230 Federal Register / Vol. 71, No. 155 / Friday, August 11, 2006 / Notices 

Federal Deposit Insurance Corporation. 

Robert E. Feldman, 

Executive Secretary. 

[FR Doc. E6–13151 Filed 8–10–06; 8:45 am] 

BILLING CODE 6714–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR Part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The application also will be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Additional information on all bank 

holding companies may be obtained 

from the National Information Center 

website at www.ffiec.gov/nic/. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than September 7, 

2006. 

A. Federal Reserve Bank of Boston 

(Richard Walker, Community Affairs 

Officer) P.O. Box 55882, Boston, 

Massachusetts 02106-2204: 

1. Webster Financial Corporation, 

Waterbury, Connecticut; to merge with 

NewMil Bancorp, Inc., and thereby 

indirectly acquire NewMil Bank, both of 

New Milford, Connecticut. 

B. Federal Reserve Bank of San 

Francisco (Tracy Basinger, Director, 

Regional and Community Bank Group) 

101 Market Street, San Francisco, 

California 94105-1579: 

1. The Industrial Bank of Taiwan Co., 

Ltd., Taipei, Taiwan, and IBT Holdings 

Corp., Cerritos, California; to become 

bank holding companies by acquiring 

100 percent of the voting shares of 

EverTrust Bank, City of Industry, 

California. 

Board of Governors of the Federal Reserve 

System, August 8, 2006. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. E6–13137 Filed 8–10–06; 8:45 am] 

BILLING CODE 6210–01–S 

FEDERAL RESERVE SYSTEM 

Notice of Proposals to Engage in 

Permissible Nonbanking Activities or 

to Acquire Companies that are 

Engaged in Permissible Nonbanking 

Activities 

The companies listed in this notice 

have given notice under section 4 of the 

Bank Holding Company Act (12 U.S.C. 

1843) (BHC Act) and Regulation Y (12 

CFR Part 225) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 

Each notice is available for inspection 

at the Federal Reserve Bank indicated. 

The notice also will be available for 

inspection at the offices of the Board of 

Governors. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. Additional information on all 

bank holding companies may be 

obtained from the National Information 

Center website at www.ffiec.gov/nic/. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors 

not later than September 7, 2006. 

A. Federal Reserve Bank of Cleveland 

(Douglas A. Banks, Vice President) 1455 

East Sixth Street, Cleveland, Ohio 

44101-2566: 

1. National City Corporation, 

Cleveland, Ohio; to acquire Fidelity 

Federal Bank & Trust, and Fidelity 

Bankshares, Inc., and thereby indirectly 

acquire Fidelity Realty & Appraisal 

Services, Inc., all of West Palm Beach, 

Florida, and engage in real estate 

appraisal services and operating a 

savings association, pursuant to sections 

225.28(b)(2)(i) and (b)(4)(ii), of 

Regulation Y. 

Board of Governors of the Federal Reserve 

System, August 8, 2006. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc.E6–13136 Filed 8–11–06; 8:45 am] 

BILLING CODE 6210–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects 

Title: Compassion Capital Fund 

Evaluation—Intermediary Survey. 

OMB No.: New Collection. 

Description: This proposed 

information collection activity is for a 

survey to be completed by Compassion 

Capital Fund intermediary grantees as a 

part of the outcome and impact study 

components of the Compassion Capital 

Fund Evaluation. 

The Compassion Capital Fund 

Evaluation is a multi-component study 

designed to examine the effectiveness of 

the Compassion Capital Fund (CCF) in 

meeting its objective of improving the 

organizational capacity of faith-based 

and community organizations. The CCF 

program works through intermediary 

organizations to provide capacity 

building assistance to interested faithbased and community organizations. 

The purpose of this data collection 

activity is to obtain more detailed 

information about the management 

processes and service delivery and 

monitoring approaches used by CCF 

intermediaries in providing technical 

and financial assistance to increase the 

organizational capacity of faith-based 

and community organizations. 

Respondents: CCF intermediary 

grantees. 


hsrobinson on PROD1PC67 with NOTICES1
Federal Register / Vol. 71, No. 155 / Friday, August 11, 2006 / Notices 46231 

ANNUAL BURDEN ESTIMATES

Instrument Number of respondents 

Number of responses per 

respondent 

Average burden hours per 

response 

Total burden 

hours 

Intermediary survey ......................................................................................... 60 1 .5 30 

Estimated Total Annual Burden 

Hours: 

In compliance with the requirements 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447. Attn: ACF Reports Clearance 

Office. E-mail address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents. Consideration will be 

given to comments and suggestions 

submitted within 60 days of this 

publication. 

Dated: August 4, 2006. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 06–6841 Filed 8–10–06; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Industry Exchange Workshop on Food 

and Drug Administration Clinical Trial 

Requirements; Public Workshop 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshop. 

SUMMARY: The Food and Drug 

Administration (FDA) Detroit District, 

in cooperation with the Society of 

Clinical Research Associates (SoCRA), is 

announcing a workshop on FDA clinical 

trial statutory and regulatory 

requirements. This 2-day workshop for 

the clinical research community targets 

sponsors, monitors, clinical 

investigators, institutional review 

boards, and those who interact with 

them for the purpose of conducting 

FDA-regulated clinical research. The 

workshop will include both industry 

and FDA perspectives on proper 

conduct of clinical trials regulated by 

FDA. 

Date and Time: The public workshop 

is scheduled for Wednesday, November 

15, 2006, from 8:30 a.m. to 5 p.m. and 

Thursday, November 16, 2006, from 

8:30 a.m. to 4:30 p.m. 

Location: The public workshop will 

be held at the Sheraton Indianapolis 

Hotel & Suites, 8787 Keystone Crossing, 

Indianapolis, IN 46240, 317–846–2700, 

FAX: 317–574–6775. 

Contact: Nancy Bellamy, Food and 

Drug Administration, 300 River Pl., 

suite 5900, Detroit, MI, 48207, 313–393–

8143, FAX: 313–393–8139, e-mail: 

nancy.bellamy@fda.hhs.gov. 

Registration: Send registration 

information (including name, title, firm 

name, address, telephone, and fax 

number) and the registration fee of $575 

(member), $650 (nonmember), or $525 

(Government employee nonmember). 

(Registration fee for nonmembers 

includes a 1-year membership.) The 

registration fee for FDA employees is 

waived. Make the registration fee 

payable to SoCRA, 530 West Butler 

Ave., suite 109, Chalfont, PA, 18914. To 

register via the Internet go tohttp:// 

www.socra.org/html/ 

FDAlConference.htm (FDA has 

verified the Web site address, but is not 

responsible for subsequent changes to 

the Web site after this document 

publishes in the Federal Register). 

The registrar will also accept payment 

by major credit cards. For more 

information on the meeting, or for 

questions on registration, contact 800–

SoCRA92 (800–762–7292), or 215–822–

8644, or via e-mail: socramail@aol.com. 

Attendees are responsible for their own 

accommodations. To make reservations 

at the Sheraton Indianapolis Hotel & 

Suites, at the reduced conference rate, 

contact the Sheraton Indianapolis Hotel 

& Suites (see Location) before October 

22, 2006. The registration fee will be 

used to offset the expenses of hosting 

the conference, including meals, 

refreshments, meeting rooms, and 

materials. 

Space is limited, therefore interested 

parties are encouraged to register early. 

Limited onsite registration may be 

available. Please arrive early to ensure 

prompt registration. If you need special 

accommodations due to a disability, 

please contact Nancy Bellamy (see 

Contact) at least 7 days in advance of 

the workshop. 

SUPPLEMENTARY INFORMATION: The 

workshop on FDA clinical trials 

statutory and regulatory requirements 

helps fulfill the Department of Health 

and Human Services’ and FDA’s 

important mission to protect the public 

health by educating researchers on 

proper conduct of clinical trials. Topics 

for discussion include the following: (1) 

FDA regulation of the conduct of 

clinical research; (2) medical device, 

drug, biological product and food 

aspects of clinical research; (3) 

investigator initiated research; (4) preinvestigational new drug application 

meetings and FDA meeting process; (5) 

informed consent requirements; (6) 

ethics in subject enrollment; (7) FDA 

regulation of institutional review 

boards; (8) electronic records 

requirements; (9) adverse event 

reporting; (10) how FDA conducts 

bioresearch inspections; and (11) what 

happens after the FDA inspection. FDA 

has made education of the research 

community a high priority to ensure the 

quality of clinical data and protect 

research subjects. The workshop helps 

to implement the objectives of section 

406 of the FDA Modernization Act (21 

U.S.C. 393) and the FDA Plan for 

Statutory Compliance, which includes 

working more closely with stakeholders 

and ensuring access to needed scientific 

and technical expertise. The workshop 

also furthers the goals of the Small 

Business Regulatory Enforcement 

Fairness Act (Public Law 104–121) by 

providing outreach activities by 

Government agencies directed to small 

businesses. 


hsrobinson on PROD1PC67 with NOTICES1